KAINOS LaboratoriesTSE:4556 39 FCF Yield % is 5.48 as of Jul. 11, 2026, which is 48% below its 10-year median of 10.54. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 855 Medical Devices & Instruments companies, KAINOS Laboratories ranks better than 84.09% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for KAINOS Laboratories's FCF Yield % or its related term are showing as below:
TSE:4556'
s FCF Yield % Range Over the Past 10 Years
Min: 3.44 Med: 10.54 Max: 18.35
Current: 5.48
During the past 13 years, the highest FCF Yield % of KAINOS Laboratories was 18.35%. The lowest was 3.44%. And the median was 10.54%.
TSE:4556's FCF Yield % is ranked better than 84.09% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.39
vs TSE:4556: 5.48
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
KAINOS Laboratories FCF Yield % Related Terms
KAINOS Laboratories FCF Yield % Historical Data
* Premium members only.
The historical data trend for KAINOS Laboratories's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4556 vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KAINOS Laboratories FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's FCF Yield % distribution charts can be found below:
* The bar in red indicates where KAINOS Laboratories's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAINOS Laboratories (TSE:4556) has a FCF Yield % of 5.48 as of Jul. 11, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on KAINOS Laboratories and its competitors. This is 48% below median its historical median of 10.54. Over the past decade, KAINOS Laboratories' FCF Yield % has ranged from 3.44 to 18.35. According to the industry distribution chart, KAINOS Laboratories ranks #136 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 15.9%.
Is KAINOS Laboratories' FCF Yield % too high?
KAINOS Laboratories' current FCF Yield % of 5.48 is 48% below median its 10-year median of 10.54. Over the past 10 years, this metric has ranged from a low of 3.44 to a high of 18.35. Based on the distribution chart, KAINOS Laboratories ranks #136 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KAINOS Laboratories ranks #136 out of 855 companies for FCF Yield %. This places KAINOS Laboratories in the top 16% of its industry — outperforming the majority of peers. Historically, KAINOS Laboratories' own FCF Yield % has ranged from 3.44 to 18.35 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on KAINOS Laboratories and its competitors. KAINOS Laboratories's current FCF Yield % is 5.48, which is 48% below median its own 10-year median of 10.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current FCF Yield % is 5.48, which is 48% below median its 10-year median of 10.54. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current FCF Yield % is 5.48 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?
Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued.
The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99.
GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.
Key valuation signals for TSE:4556:
FCF Yield %: 5.48 (48% below median its 10-year median of 10.54)
GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score
Get the complete analysis for TSE:4556
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4556 has been successfully added to your 
